Medical Offices of Manhattan - Upper East Side

Medical Offices of Manhattan operates a multi-specialty practice on the Upper East Side of New York, NY, providing integrated primary care alongside subspecialty services in endocrinology, cardiology, gastroenterology, dermatology, and podiatry. The clinic has expanded its endocrinology and weight management offerings to include GLP-1 receptor agonist therapies, specifically semaglutide and tirzepatide, which are administered under physician supervision as part of comprehensive metabolic health programs. With a 4.7-star rating across more than 3,100 Google reviews, the practice serves a diverse patient population seeking both routine preventive care and targeted interventions for chronic conditions.

The weight loss programs at Medical Offices of Manhattan center on semaglutide and tirzepatide peptide therapies, both of which modulate incretin pathways to reduce appetite and improve glycemic control. Semaglutide is typically initiated at 0.25 mg subcutaneously per week and titrated based on patient response and tolerability, while tirzepatide combines GIP and GLP-1 receptor agonism for dual-pathway metabolic effects. These peptides are prescribed following baseline metabolic panels, thyroid function tests, and cardiovascular risk assessments conducted by the clinic's endocrinologists. Patients undergo regular follow-up visits to monitor weight trends, adjust dosing, and address any gastrointestinal side effects or contraindications. The clinic integrates peptide therapy with nutritional counseling and activity recommendations, though the pharmacologic intervention remains the primary modality for patients with BMI over 27 who have not achieved goals through lifestyle modification alone.

The endocrinology team includes board-certified physicians who manage not only obesity medicine but also diabetes, thyroid disorders, and metabolic syndrome. Primary care physicians within the practice coordinate care across specialties, ensuring that patients on semaglutide or tirzepatide receive appropriate cardiovascular monitoring through the in-house cardiology department, which performs EKGs and echocardiograms as clinically indicated. Gastroenterology services are available for patients requiring colonoscopy or evaluation of GI symptoms that may arise during GLP-1 therapy. This integrated model allows for same-location management of comorbidities common in weight loss candidates, including hypertension, hyperlipidemia, and prediabetes. The dermatology and podiatry departments address skin and foot health concerns that frequently accompany metabolic disease, providing a continuity of care that reduces the need for external referrals.

Patients schedule initial consultations either in person at the Upper East Side location or via telehealth, with hybrid follow-up options available based on clinical needs and patient preference. New patients complete intake forms detailing medical history, current medications, and prior weight loss attempts, and they are typically seen within two to three weeks of contact. The initial visit includes a physical examination, body composition analysis, and laboratory orders for comprehensive metabolic panel, lipid profile, hemoglobin A1c, and TSH. Peptide therapy candidates receive education on injection technique, refrigeration requirements, and expected timelines for appetite suppression and weight reduction. Follow-up visits occur every four weeks during the titration phase, then extend to every eight to twelve weeks once a maintenance dose is established. The clinic accepts most major insurance plans, though coverage for GLP-1 therapies varies by carrier and indication, and patients are informed of out-of-pocket costs during the prior authorization process.

Medical Offices of Manhattan distinguishes itself in the New York peptide therapy landscape through its multi-specialty infrastructure, which enables real-time collaboration between endocrinologists, cardiologists, and primary care providers. Patients benefit from on-site diagnostic capabilities including laboratory draws, EKG, echocardiography, and advanced imaging, which streamline the monitoring process and reduce delays in dose adjustments. The practice's high volume of reviews reflects its established presence in the Upper East Side community and its ability to accommodate both acute sick visits and chronic disease management within a single care team. Telehealth consultations extend access to patients across New York State, though initial prescriptions for controlled or high-risk medications typically require an in-person evaluation. The clinic's emphasis on evidence-based peptide protocols, transparent pricing discussions, and coordination with insurance providers positions it as a practical option for patients seeking medically supervised weight loss integrated with comprehensive primary and specialty care.